Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-15,817
Closed -$97.7K 2026
2026
Q1
$97.7K Buy
+15,817
New +$97.6K ﹤0.01% 1386
2025
Q2
Sell
-11,682
Closed -$83.3K 1805
2025
Q1
$83.3K Buy
+11,682
New +$110K ﹤0.01% 1416
2024
Q4
Sell
-14,194
Closed -$138K 2021
2024
Q3
$138K Buy
+14,194
New +$149K ﹤0.01% 1922

Other funds holding INGN

Centiva Capital's INGN Position: Q2 2026 in Review

Centiva Capital sold out of Inogen (INGN) in Q2 2026, closing a stake of 15,817 shares — an estimated $97.7K sold.

Centiva Capital first reported a position in INGN in Q3 2024 and held it in 3 quarters. The position peaked at $138K in Q3 2024. 129 funds tracked by Wall St. Rank hold INGN as of Q2 2026.

  • Centiva Capital reported no remaining Inogen position as of Q2 2026 after selling out during the quarter.
  • Centiva Capital sold 15,817 Inogen shares in Q2 2026, an estimated $97.7K.
  • Centiva Capital first reported a position in Inogen in Q3 2024 and held it in 3 quarters.
  • Centiva Capital's Inogen position peaked at $138K in Q3 2024.
  • 129 funds tracked by Wall St. Rank held Inogen as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.